0001193125-19-220977.txt : 20190917 0001193125-19-220977.hdr.sgml : 20190917 20190814132132 ACCESSION NUMBER: 0001193125-19-220977 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20190814 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CONSTELLATION PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001434418 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 200 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-714-0555 MAIL ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 200 CITY: CAMBRIDGE STATE: MA ZIP: 02142 CORRESP 1 filename1.htm CORRESP

CONSTELLATION PHARMACEUTICALS, INC.

215 First Street, Suite 200

Cambridge, MA 02142

August 14, 2019

VIA EDGAR

Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

 

Re:

Constellation Pharmaceuticals, Inc.

Registration Statement on Form S-3

File No. 333-232992

Request for Acceleration

Ladies and Gentlemen:

Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, Constellation Pharmaceuticals, Inc. (the “Registrant”) hereby requests acceleration of the effective date of its Registration Statement on Form S-3 (File No. 333-232992), so that it may become effective at 4:30 p.m. Eastern time on August 16, 2019, or as soon thereafter as practicable, or at such later time as the Registrant or its counsel may orally request via telephone call to the staff.

 

Very truly yours,

 

CONSTELLATION PHARMACEUTICALS, INC.

By:   /s/ Karen Valentine

Name:

Title:

  

Karen Valentine

Chief Legal Officer and General Counsel

 

cc:

Lia Der Marderosian

Wilmer Cutler Pickering Hale and Dorr LLP